About This Study
The purpose of this study is to learn more about a new medicine called IDP-023. We want to see if it is safe and if it can help people with certain blood cancers. We are looking for volunteers who have multiple myeloma that came back after trying at least three other cancer treatments, non-Hodgkin's lymphoma that came back after trying at least two other treatments, or acute myeloid leukemia that came back after trying at least one other treatment.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC
Study Topics
Cancer Cancer: Blood Cancer: Leukemia Cancer: Lymphoma Cancer: Myeloma